• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内肽酶-24.11抑制剂和C型心钠素受体配体对心房利钠肽诱发大鼠提睾肌小动脉反应的影响。

Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.

作者信息

Peyroux J, Beslot F, Claperon N, Fournie-Zaluski M C, Roques B P

机构信息

Laboratoire de Pharmacologie, U266 INSERM, UA 498, CNRS D. 1500, UFR des Sciences Pharmaceutiques et Biologiques, Paris, France.

出版信息

Br J Pharmacol. 1995 Dec;116(8):3117-24. doi: 10.1111/j.1476-5381.1995.tb15113.x.

DOI:10.1111/j.1476-5381.1995.tb15113.x
PMID:8719785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1909177/
Abstract
  1. The present study examined the effect of exogenous atrial natriuretric peptide (ANP), alone or in presence of inhibitors of the two major mechanisms for clearing ANP, metabolism by neutral endopeptidase-24.11 (NEP) and internalization by C-ANP receptors, on arteriolar responses using intravital microscopy on the rat cremaster muscle after intravenous or topical administration of the peptide. 2. Topical application of ANP (3 x 10(-10) to 3 x 10(-8) M) produced a gradual increase in arteriolar diameter. NEP inhibitors, thiorphan (30 mg kg-1, i.v.), kelatorphan (10 mg kg-1, i.v.) and retrothiorphan (25 mg kg-1, i.v.) alone, did not significantly affect vascular tone but caused significant potentiation of the arteriolar responses to topically applied ANP. 3. When given as an i.v. bolus, ANP dilates skeletal arterioles at a high dose (20 micrograms kg-1). At a lower dose (10 micrograms kg-2), ANP alone or with retrothiorphan or the C-ANP receptor ligand C-ANP (4-23) did not produce any arteriolar responses, while after the combined administration of the two inhibitors, an increase in arteriolar diameter was induced. 4. These results indicate that low doses of topically applied ANP dilate rat cremaster arterioles and that the vasodilator responses can be potentiated by NEP inhibition. When given as an i.v. bolus, a high dose of ANP can also dilate skeletal arterioles. However at a lower dose the rapid metabolism of the peptide prevents it from producing its action.
摘要
  1. 本研究通过在大鼠提睾肌上进行活体显微镜观察,静脉内或局部给予心房利钠肽(ANP)后,单独或在存在清除ANP的两种主要机制(中性内肽酶-24.11(NEP)代谢和C型ANP受体内化)抑制剂的情况下,研究了外源性ANP对小动脉反应的影响。2. 局部应用ANP(3×10⁻¹⁰至3×10⁻⁸ M)可使小动脉直径逐渐增加。NEP抑制剂,如硫肽素(30 mg kg⁻¹,静脉内注射)、凯托肽素(10 mg kg⁻¹,静脉内注射)和逆转硫肽素(25 mg kg⁻¹,静脉内注射)单独使用时,对血管张力没有显著影响,但可显著增强局部应用ANP时的小动脉反应。3. 静脉推注时,高剂量(20微克 kg⁻¹)的ANP可扩张骨骼肌小动脉。低剂量(10微克 kg⁻²)时,单独的ANP或与逆转硫肽素或C型ANP受体配体C-ANP(4-23)联合使用均未产生任何小动脉反应,而联合使用两种抑制剂后,可诱导小动脉直径增加。4. 这些结果表明,低剂量局部应用的ANP可扩张大鼠提睾肌小动脉,NEP抑制可增强血管舒张反应。静脉推注时,高剂量的ANP也可扩张骨骼肌小动脉。然而,低剂量时,该肽的快速代谢使其无法发挥作用。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/1909177/ad9cabbbf2cf/brjpharm00181-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/1909177/223412fa69d5/brjpharm00181-0045-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/1909177/ad9cabbbf2cf/brjpharm00181-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/1909177/223412fa69d5/brjpharm00181-0045-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5bd/1909177/ad9cabbbf2cf/brjpharm00181-0046-a.jpg

相似文献

1
Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.内肽酶-24.11抑制剂和C型心钠素受体配体对心房利钠肽诱发大鼠提睾肌小动脉反应的影响。
Br J Pharmacol. 1995 Dec;116(8):3117-24. doi: 10.1111/j.1476-5381.1995.tb15113.x.
2
Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.抑制中性内肽酶可增强心房利钠肽对急性环孢素诱导的肾毒性的作用。
Nephron. 2000 Nov;86(3):298-305. doi: 10.1159/000045785.
3
Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.中性内肽酶抑制可增强利钠肽在肾素转基因大鼠中的作用。
Hypertens Res. 1996 Dec;19(4):229-38. doi: 10.1291/hypres.19.229.
4
Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.清醒大鼠基础状态及容量扩张刺激后的血浆心房钠尿肽浓度与血流动力学:内肽酶抑制剂SCH 39.370及清除受体配体C-ANF-(4-23)的作用
Endocrinology. 1992 Feb;130(2):755-65. doi: 10.1210/endo.130.2.1531129.
5
Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.大鼠对心房利钠肽、内肽酶24.11抑制剂及C型心房钠尿肽受体配体的反应
Br J Pharmacol. 1992 Sep;107(1):50-7. doi: 10.1111/j.1476-5381.1992.tb14462.x.
6
Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.硫奥芬,一种内肽酶24.11的抑制剂,可增强心钠素的利钠活性。
J Cardiovasc Pharmacol. 1989 Sep;14(3):419-24. doi: 10.1097/00005344-198909000-00010.
7
Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.内肽酶24.11的特异性抑制剂在体外和体内均可抑制心钠素的代谢。
Mol Cell Endocrinol. 1989 Feb;61(2):201-8. doi: 10.1016/0303-7207(89)90131-7.
8
Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
J Cardiovasc Pharmacol. 1994 Mar;23(3):358-64.
9
Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.中性内肽酶抑制剂与麻醉犬体内心房钠尿肽 C 受体配体的相互作用。
Clin Exp Hypertens. 1995 Aug;17(6):861-76. doi: 10.3109/10641969509033640.
10
Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts.中性内肽酶抑制剂对作为旁分泌因子的内源性心房利钠肽在培养心肌成纤维细胞中的作用。
Br J Pharmacol. 2000 Nov;131(6):1204-10. doi: 10.1038/sj.bjp.0703679.

引用本文的文献

1
Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway.心钠肽通过小窝介导的细胞旁路增强微血管白蛋白通透性。
Cardiovasc Res. 2012 Jan 1;93(1):141-51. doi: 10.1093/cvr/cvr279. Epub 2011 Oct 24.
2
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.双重血管紧张素转换酶和中性内肽酶24-11抑制剂米沙坦对肥胖Zucker大鼠胰岛素敏感性的急性影响。
Br J Pharmacol. 2001 Jun;133(4):495-502. doi: 10.1038/sj.bjp.0704098.

本文引用的文献

1
Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.中性内肽酶24.11:结构、抑制作用以及实验与临床药理学
Pharmacol Rev. 1993 Mar;45(1):87-146.
2
Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex.兔肾皮质血管平滑肌细胞中中性内肽酶的特性研究
Am J Physiol. 1993 Jan;264(1 Pt 2):F45-52. doi: 10.1152/ajprenal.1993.264.1.F45.
3
Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch.肽酶调节仓鼠颊囊内缓激肽诱导的小动脉扩张。
Am J Physiol. 1994 Jan;266(1 Pt 2):H93-8. doi: 10.1152/ajpheart.1994.266.1.H93.
4
Atrial natriuretic factor receptors and signal transduction mechanisms.心房利钠因子受体与信号转导机制。
Pharmacol Rev. 1993 Dec;45(4):455-97.
5
Neutral endopeptidase in the heart. Neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation.
Circ Res. 1994 Oct;75(4):770-9. doi: 10.1161/01.res.75.4.770.
6
The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.脑啡肽酶抑制剂硫喷妥在小鼠中表现出抗伤害感受活性。
Nature. 1980 Nov 20;288(5788):286-8. doi: 10.1038/288286a0.
7
Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.通过逆-硫喷妥因实现脑啡肽酶与血管紧张素转换酶抑制作用的完全区分。
Proc Natl Acad Sci U S A. 1983 Jun;80(11):3178-82. doi: 10.1073/pnas.80.11.3178.
8
Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
Life Sci. 1984 Aug 27;35(9):1023-30. doi: 10.1016/0024-3205(84)90669-6.
9
The response of skeletal muscle arterioles to common carotid occlusion.骨骼肌小动脉对颈总动脉闭塞的反应。
Microvasc Res. 1974 May;7(3):321-5. doi: 10.1016/0026-2862(74)90019-3.
10
An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy.一种用于通过体内显微镜研究血管的开放性提睾肌制备方法。
Microvasc Res. 1973 May;5(3):384-94. doi: 10.1016/0026-2862(73)90054-x.